Fig. 2From: Synergy between hemagglutinin 2 (HA2) subunit of influenza fusogenic membrane glycoprotein and oncolytic Newcastle disease virus suppressed tumor growth and further enhanced by Immune checkpoint PD-1 blockade Schematic overview of all experimental procedures. The blue arrow indicates the time schedule of experiments from day 0 (subcutaneous injection of TC-1 tumor cells) to day 42 (final monitoring and evaluation of tumor)Back to article page